Dyne Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 05/15/2026 | 30.79 M | $558.15 M | 75.52% | 23.97% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 13.65 M | $247.43 M | -1.73% | 10.63% |
| BLACKROCK, INC. | 05/13/2026 | 11.70 M | $212.12 M | 4.55% | 9.11% |
| ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC | 05/14/2026 | 9.13 M | $165.54 M | 0.00% | 7.11% |
| FMR LLC | 05/15/2026 | 8.91 M | $161.52 M | 35.60% | 6.94% |
| ORBIS ALLAN GRAY LTD | 05/15/2026 | 6.76 M | $122.60 M | 40.82% | 5.26% |
| STATE STREET CORP | 05/15/2026 | 6.65 M | $120.63 M | -0.58% | 5.18% |
| 05/15/2026 | 6.41 M | $116.12 M | 100.00% | 4.99% | |
| PERCEPTIVE ADVISORS LLC | 05/29/2026 | 4.67 M | $84.65 M | 34.20% | 3.64% |
| FCPM III SERVICES B.V. | 05/15/2026 | 4.64 M | $84.20 M | -14.98% | 3.62% |
| TCG CROSSOVER MANAGEMENT, LLC | 05/15/2026 | 4.62 M | $83.67 M | 0.00% | 3.59% |
| 05/08/2026 | 4.16 M | $75.46 M | 100.00% | 3.24% | |
| VESTAL POINT CAPITAL, LP | 05/15/2026 | 4.00 M | $72.52 M | 3,233.33% | 3.11% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 3.50 M | $63.54 M | 7.38% | 2.73% |
| JPMORGAN CHASE & CO | 05/13/2026 | 3.25 M | $55.60 M | -8.35% | 2.53% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 3.18 M | $57.56 M | -2.30% | 2.47% |
| FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2026 | 3.15 M | $57.17 M | 0.00% | 2.45% |
| ORBIMED ADVISORS LLC | 05/15/2026 | 2.92 M | $52.90 M | 32.50% | 2.27% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 2.33 M | $42.22 M | 0.20% | 1.81% |
| SIREN, L.L.C. | 05/14/2026 | 2.23 M | $40.41 M | -36.36% | 1.74% |
| VR ADVISER, LLC | 05/15/2026 | 2.17 M | $39.41 M | 0.00% | 1.69% |
| FRANKLIN RESOURCES INC | 05/13/2026 | 2.01 M | $36.42 M | 0.12% | 1.56% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 2.00 M | $36.26 M | -24.53% | 1.56% |
| SAMLYN CAPITAL, LLC | 05/15/2026 | 1.92 M | $34.86 M | 28.76% | 1.50% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.72 M | $31.24 M | -24.53% | 1.34% |
| BRAIDWELL LP | 05/15/2026 | 1.68 M | $30.49 M | 13.78% | 1.31% |
| PALO ALTO INVESTORS LP | 05/15/2026 | 1.65 M | $29.97 M | 12.28% | 1.29% |
| SOFINNOVA INVESTMENTS, INC. | 05/15/2026 | 1.63 M | $29.62 M | -27.52% | 1.27% |
| VIVO CAPITAL, LLC | 05/20/2026 | 1.56 M | $28.24 M | -40.44% | 1.21% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 1.44 M | $26.17 M | 63.47% | 1.12% |
| ABRDN PLC | 04/29/2026 | 1.43 M | $25.93 M | 29.08% | 1.11% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.41 M | $25.53 M | 0.20% | 1.10% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 1.40 M | $25.38 M | 12.00% | 1.09% |
| FIERA CAPITAL CORP | 05/12/2026 | 1.38 M | $25.03 M | 100.00% | 1.07% |
| POLAR CAPITAL HOLDINGS PLC | 05/15/2026 | 1.36 M | $24.64 M | 7.09% | 1.06% |
| NORTHERN TRUST CORP | 05/14/2026 | 1.20 M | $21.73 M | 9.76% | 0.93% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/15/2026 | 1.16 M | $21.00 M | 0.61% | 0.90% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2026 | 1.00 M | $18.13 M | -80.67% | 0.78% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 05/15/2026 | 972.20 K | $17.63 M | 6.49% | 0.76% |
| SATURN V CAPITAL MANAGEMENT LLC | 05/15/2026 | 966.61 K | $17.52 M | -45.96% | 0.75% |
| DIMENSIONAL FUND ADVISORS LP | 05/07/2026 | 951.59 K | $17.24 M | 870.28% | 0.74% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 947.44 K | $17.18 M | 100.00% | 0.74% |
| MORGAN STANLEY | 05/15/2026 | 929.00 K | $16.84 M | -23.45% | 0.72% |
| SQUAREPOINT OPS LLC | 05/15/2026 | 834.18 K | $15.12 M | 226.92% | 0.65% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 05/15/2026 | 821.85 K | $14.90 M | -27.84% | 0.64% |
| BAKER BROS. ADVISORS LP | 05/15/2026 | 813.45 K | $14.75 M | 0.00% | 0.63% |
| NUVEEN, LLC | 04/30/2026 | 718.33 K | $13.02 M | 15.62% | 0.56% |
| ARROWMARK COLORADO HOLDINGS LLC | 05/15/2026 | 673.95 K | $12.22 M | -3.81% | 0.52% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/13/2026 | 619.46 K | $11.23 M | -4.65% | 0.48% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 533.60 K | $9.67 M | 13.38% | 0.42% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dyne Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 294 institutional investors and hedge funds held shares of Dyne Therapeutics Inc. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 30.79 M
JANUS HENDERSON GROUP PLC: 13.65 M
BlackRock, Inc.: 11.7 M
Atlas Venture Life Science Advisors, LLC: 9.13 M
FMR LLC: 8.91 M
Orbis Allan Gray Ltd: 6.76 M
146.25% of Dyne Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 197.98 M shares in the last 24 months. This purchase volume represents approximately $3.50 B in transactions.